Free Trial

PureTech Health (PRTC) Competitors

PureTech Health logo
$16.93 +0.18 (+1.07%)
Closing price 04/17/2025 03:51 PM Eastern
Extended Trading
$16.63 -0.30 (-1.77%)
As of 04/17/2025 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PRTC vs. GLPG, BHC, CNTA, AGIO, ARQT, CGON, KNSA, APGE, IDYA, and ANIP

Should you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Galapagos (GLPG), Bausch Health Companies (BHC), Centessa Pharmaceuticals (CNTA), Agios Pharmaceuticals (AGIO), Arcutis Biotherapeutics (ARQT), CG Oncology (CGON), Kiniksa Pharmaceuticals (KNSA), Apogee Therapeutics (APGE), IDEAYA Biosciences (IDYA), and ANI Pharmaceuticals (ANIP). These companies are all part of the "pharmaceutical products" industry.

PureTech Health vs.

Galapagos (NASDAQ:GLPG) and PureTech Health (NASDAQ:PRTC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Galapagos has higher revenue and earnings than PureTech Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Galapagos$275.65M5.93$80.16MN/AN/A
PureTech Health$3.33M121.14-$65.70MN/AN/A

Company Net Margins Return on Equity Return on Assets
GalapagosN/A N/A N/A
PureTech Health N/A N/A N/A

In the previous week, Galapagos had 7 more articles in the media than PureTech Health. MarketBeat recorded 9 mentions for Galapagos and 2 mentions for PureTech Health. PureTech Health's average media sentiment score of 0.79 beat Galapagos' score of 0.50 indicating that PureTech Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Galapagos
3 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
PureTech Health
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Galapagos has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500.

Galapagos received 457 more outperform votes than PureTech Health when rated by MarketBeat users. Likewise, 63.84% of users gave Galapagos an outperform vote while only 45.00% of users gave PureTech Health an outperform vote.

CompanyUnderperformOutperform
GalapagosOutperform Votes
466
63.84%
Underperform Votes
264
36.16%
PureTech HealthOutperform Votes
9
45.00%
Underperform Votes
11
55.00%

32.5% of Galapagos shares are held by institutional investors. Comparatively, 0.0% of PureTech Health shares are held by institutional investors. 2.9% of Galapagos shares are held by company insiders. Comparatively, 5.3% of PureTech Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Galapagos currently has a consensus target price of $25.33, suggesting a potential upside of 2.09%. PureTech Health has a consensus target price of $45.00, suggesting a potential upside of 167.94%. Given PureTech Health's stronger consensus rating and higher possible upside, analysts plainly believe PureTech Health is more favorable than Galapagos.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Galapagos
4 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
PureTech Health
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

Summary

PureTech Health beats Galapagos on 8 of the 14 factors compared between the two stocks.

Get PureTech Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRTC vs. The Competition

MetricPureTech HealthPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$403.40M$6.48B$5.30B$7.37B
Dividend YieldN/A3.24%5.11%4.31%
P/E RatioN/A6.8621.7117.79
Price / Sales121.14230.18378.3096.40
Price / CashN/A65.6738.1534.64
Price / Book0.995.906.433.98
Net Income-$65.70M$142.26M$3.20B$247.33M
7 Day Performance24.59%7.69%4.86%4.34%
1 Month Performance-6.63%-14.07%-9.80%-7.83%
1 Year Performance-37.65%-10.22%10.77%1.29%

PureTech Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRTC
PureTech Health
2.8308 of 5 stars
$16.93
+1.1%
$45.00
+165.8%
-37.1%$406.64M$3.33M0.00100Upcoming Earnings
Short Interest ↓
GLPG
Galapagos
0.6546 of 5 stars
$24.20
+0.8%
$25.33
+4.7%
-15.6%$1.59B$275.65M0.001,310Upcoming Earnings
High Trading Volume
BHC
Bausch Health Companies
4.0825 of 5 stars
$4.33
+0.2%
$7.17
+65.5%
-40.8%$1.59B$9.63B-36.0819,900Short Interest ↑
CNTA
Centessa Pharmaceuticals
2.9316 of 5 stars
$11.94
+3.2%
$27.71
+132.1%
+14.1%$1.59B$6.85M-7.80200Gap Down
AGIO
Agios Pharmaceuticals
3.8711 of 5 stars
$27.52
+3.1%
$56.57
+105.6%
-4.7%$1.58B$36.50M2.43390Analyst Revision
ARQT
Arcutis Biotherapeutics
2.9241 of 5 stars
$12.94
+2.8%
$18.80
+45.3%
+26.9%$1.54B$196.54M-7.23150Gap Up
CGON
CG Oncology
1.109 of 5 stars
$20.06
+4.0%
$63.88
+218.4%
-43.3%$1.53B$1.14M-14.1361Analyst Forecast
Gap Down
KNSA
Kiniksa Pharmaceuticals
2.425 of 5 stars
$20.69
+7.1%
$37.17
+79.6%
+19.2%$1.50B$423.24M-147.78220Upcoming Earnings
Analyst Forecast
Insider Trade
News Coverage
Positive News
Gap Down
APGE
Apogee Therapeutics
2.0773 of 5 stars
$33.28
+4.7%
$92.17
+176.9%
-35.7%$1.50BN/A-13.7591
IDYA
IDEAYA Biosciences
3.5552 of 5 stars
$17.11
+2.1%
$53.58
+213.2%
-57.5%$1.50B$7M-5.1880Positive News
Gap Up
ANIP
ANI Pharmaceuticals
3.6208 of 5 stars
$68.72
+0.9%
$79.75
+16.1%
+5.7%$1.50B$614.38M-124.95600Analyst Upgrade
News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:PRTC) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners